Within the calcium chloride model, tail vein administration of 2 mg of an IL-6R blocking antibody, commencing one day prior to aneurysm induction and repeated at a dose of 0.25 mg intraperitoneally every week, reduced the size of the aneurysm that developed after 6 weeks compared to controls [37]. Here, IL6R is linked to aneurysm.